Conversely, in our experience, p16 was not predictive for HPV infection in MESCC, as reported for hypopharyngeal and nasopharyngeal cancers [24] and in geographical areas where p16 does not seem to be a surrogate marker of HPV positivity in oral cavity and laryngeal carcinoma [29]. This evidence concerns the gene CDKN2A and laryngeal carcinoma.